SLC5A2 and diabetes mellitus: SGLT2i have a decreasing effect on uric acid levels, as shown by two meta-analyses, of which the more recent one by Yip et al. in 2022 determined a beneficial effect of SGLT2 inhibition on reducing serum urate concentrations in patients with and without DM [78].